PMID:18519731
Citation |
Hansen, S , Lewis, K and Vulić, M (2008) Role of global regulators and nucleotide metabolism in antibiotic tolerance in Escherichia coli. Antimicrob. Agents Chemother. 52:2718-26 |
---|---|
Abstract |
Bacterial populations produce a small number of persister cells that exhibit multidrug tolerance. Persister cells are largely responsible for the antibiotic recalcitrance of biofilm infections. The mechanism of persister cell formation largely remains unknown due to the challenges in identifying persister genes. We screened an ordered comprehensive library of 3,985 Escherichia coli knockout strains to identify mutants with altered antibiotic tolerance. Stationary-state cultures in 96-well plates were exposed to ofloxacin at a concentration which allows only tolerant persister cells to survive. The persister cell level of each culture was determined. A total of 150 mutants with decreased persistence were identified in the initial screen, and subsequent validation confirmed that neither the growth rate nor the ofloxacin MIC was affected for 10 of them. The genes affected in these strains were dnaJ and dnaK (chaperones), apaH (diadenosine tetraphosphatase), surA (peptidyl-prolyl cis-trans isomerase), fis and hns (global regulators), hnr (response regulator of RpoS), dksA (transcriptional regulator of rRNA transcription), ygfA (5-formyl-tetrahydrofolate cyclo-ligase), and yigB (flavin mononucleotide [FMN] phosphatase). The prominent presence of global regulators among these strains pointed to the likely redundancy of persister cell formation mechanisms: the elimination of a regulator controlling several redundant persister genes would be expected to produce a phenotype. This observation is consistent with previous findings for a possible role of redundant genes such as toxin/antitoxin modules in persister cell formation. ygfA and yigB were of special interest. The mammalian homolog of YgfA (methenyltetrahydrofolate synthetase) catalyzes the conversion of 5-formyl-tetrahydrofolate (THF) into the rapidly degraded 5,10-methenyl-THF, depleting the folate pool. The YigB protein is a phosphatase of FMN which would deplete the pool of this cofactor. Stochastic overexpression of these genes could lead to dormancy and, hence, tolerance by depleting the folate and FMN pools, respectively. Consistent with this scenario, the overexpression of both genes produced increased tolerance to ofloxacin. |
Links |
PubMed PMC2493092 Online version:10.1128/AAC.00144-08 |
Keywords |
Anti-Bacterial Agents/pharmacology; Drug Resistance, Multiple, Bacterial; Escherichia coli/drug effects; Escherichia coli/genetics; Escherichia coli/metabolism; Escherichia coli Proteins/genetics; Escherichia coli Proteins/metabolism; Gene Expression Regulation, Bacterial/drug effects; Microbial Sensitivity Tests; Mutation; Nucleotides/metabolism; Ofloxacin/pharmacology |
edit table |
Main Points of the Paper
Please summarize the main points of the paper.
Materials and Methods Used
Please list the materials and methods used in this paper (strains, plasmids, antibodies, etc).
Phenotype Annotations
See Help:AnnotationTable for details on how to edit this table.
<protect>
Phenotype of | Taxon Information | Genotype Information (if known) | Condition Information | OMP ID | OMP Term Name | ECO ID | ECO Term Name | Notes | Status |
---|---|---|---|---|---|---|---|---|---|
a mutation or genetic difference within a strain |
|
|
|
The deletion of fis gene and insertion of Kanamycin resistant cassette caused a slight level of persistence toward Ofloxacin. See Figure 2. |
|||||
a mutation or genetic difference within a strain |
|
|
|
The deletion of hns gene and insertion of Kanamycin resistant cassette caused a slight level of persistence toward Ofloxacin. See Figure 2. |
|||||
a mutation or genetic difference within a strain |
|
|
|
The deletion of hnr gene and insertion of Kanamycin resistant cassette caused a slight level of persistence toward Ofloxacin. See Figure 2. |
|||||
a mutation or genetic difference within a strain |
|
|
|
The deletion of dksA gene and insertion of Kanamycin resistant cassette caused a slight level of persistence toward Ofloxacin. See Figure 2. |
|||||
a mutation or genetic difference within a strain |
|
|
|
The deletion of apaH gene and insertion of Kanamycin resistant cassette caused a slight level of persistence toward Ofloxacin. See Figure 2. |
|||||
a mutation or genetic difference within a strain |
|
|
|
The deletion of surA gene and insertion of Kanamycin resistant cassette caused a slight level of persistence toward Ofloxacin. See Figure 2. |
|||||
a mutation or genetic difference within a strain |
|
|
|
The deletion of dnaJ gene and insertion of Kanamycin resistant cassette caused a slight level of persistence toward Ofloxacin. See Figure 2. |
|||||
a mutation or genetic difference within a strain |
|
|
|
The deletion of dnaK gene and insertion of Kanamycin resistant cassette caused a slight level of persistence toward Ofloxacin. See Figure 2. |
|||||
a mutation or genetic difference within a strain |
|
|
|
The deletion of yigB gene and insertion of Kanamycin resistant cassette caused a slight level of persistence toward Ofloxacin. See Figure 2. |
|||||
a mutation or genetic difference within a strain |
|
|
|
The deletion of ygfA gene and insertion of Kanamycin resistant cassette caused a slight level of persistence toward Ofloxacin. See Figure 2. |
|||||
a mutation or genetic difference within a strain |
|
|
|
The deletion of the recA gene and replacement with the Kanamycin cassette conferred increased sensitivity toward ofloxacin. |
|||||
a mutation or genetic difference within a strain |
|
|
|
The deletion of the recB gene and replacement with the Kanamycin cassette conferred increased sensitivity toward ofloxacin. |
|||||
a mutation or genetic difference within a strain |
|
|
|
The deletion of the recG gene and replacement with the Kanamycin cassette conferred increased sensitivity toward ofloxacin. |
|||||
a mutation or genetic difference within a strain |
|
|
|
The deletion of the recJ gene and replacement with the Kanamycin cassette conferred increased sensitivity toward ofloxacin. |
|||||
a mutation or genetic difference within a strain |
|
|
|
The deletion of the recN gene and replacement with the Kanamycin cassette conferred increased sensitivity toward ofloxacin. |
|||||
a mutation or genetic difference within a strain |
|
|
|
The deletion of the recQ gene and replacement with the Kanamycin cassette conferred increased sensitivity toward ofloxacin. |
|||||
a mutation or genetic difference within a strain |
|
|
|
The deletion of the ruvA gene and replacement with the Kanamycin cassette conferred increased sensitivity toward ofloxacin. |
|||||
a mutation or genetic difference within a strain |
|
|
|
The deletion of the ruvB gene and replacement with the Kanamycin cassette conferred increased sensitivity toward ofloxacin. |
|||||
a mutation or genetic difference within a strain |
|
|
|
The deletion of the xseA gene and replacement with the Kanamycin cassette conferred increased sensitivity toward ofloxacin. |
|||||
a mutation or genetic difference within a strain |
|
|
|
The deletion of the xseB gene and replacement with the Kanamycin cassette conferred increased sensitivity toward ofloxacin. |
|||||
a mutation or genetic difference within a strain |
|
|
|
The deletion of the ygfA gene caused a significant decrease of persistence cells grown to stationary phase with ofloxacin. See figure 4 for experimental results. |
|||||
a mutation or genetic difference within a strain |
|
|
|
The deletion of the ssrS gene caused minimal decrease in persister cells compared to the deletion of the ygfA gene with ofloxin. See figure 4 for experimental results. |
|||||
a mutation or genetic difference within a strain |
|
|
|
The double deletion of the ygfA and ssrS genes caused a significant decrease in persister cells. See figure 4 for full experimental results. |
| ||||
edit table |
</protect>
Notes
References
See Help:References for how to manage references in omp dev.